Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging

Steven H. Liang, Jinshan Michael Chen, Marc D. Normandin, Jeanne S. Chang, George Chang, Christine K. Taylor, Patrick Trapa, Mark S. Plummer, Kimberly S. Para, Edward L. Conn, Lori Lopresti‐Morrow, Lorraine F. Lanyon, James M. Cook, K. Richter, Charlie E. Nolan, Joel B. Schachter, Fouad Janat, Ye Che, Veerabahu Shanmugasundaram, Bruce A. Lefker, Bradley E. Enerson, Elijahu Livni, Lu Wang, Nicolas J. Guehl, Debasis Patnaik, Florence F. Wagner, Roy H. Perlis, Edward B. Holson, Stephen J. Haggarty, Georges El Fakhri, Ravi G. Kurumbail, Neil VasdevAngewandte 2016 · DOI

Abstract

Glycogen synthase kinase-3 (GSK-3) regulates multiple cellular processes in diabetes, oncology, and neurology. N-(3-(1H-1,2,4-triazol-1-yl)propyl)-5-(3-chloro-4-methoxyphenyl)oxazole-4-carboxamide (PF-04802367 or PF-367) has been identified as a highly potent inhibitor, which is among the most selective antagonists of GSK-3 to date. Its efficacy was demonstrated in modulation of tau phosphorylation in vitro and in vivo. Whereas the kinetics of PF-367 binding in brain tissues are too fast for an effective therapeutic agent, the pharmacokinetic profile of PF-367 is ideal for discovery of radiopharmaceuticals for GSK-3 in the central nervous system. A (11) C-isotopologue of PF-367 was synthesized and preliminary PET imaging studies in non-human primates confirmed that we have overcome the two major obstacles for imaging GSK-3, namely, reasonable brain permeability and displaceable binding.
BibTeX
@inproceedings{liang2016discovery,
  author = {Steven H. Liang and Jinshan Michael Chen and Marc D. Normandin and Jeanne S. Chang and George Chang and Christine K. Taylor and Patrick Trapa and Mark S. Plummer and Kimberly S. Para and Edward L. Conn and Lori Lopresti‐Morrow and Lorraine F. Lanyon and James M. Cook and K. Richter and Charlie E. Nolan and Joel B. Schachter and Fouad Janat and Ye Che and Veerabahu Shanmugasundaram and Bruce A. Lefker and Bradley E. Enerson and Elijahu Livni and Lu Wang and Nicolas J. Guehl and Debasis Patnaik and Florence F. Wagner and Roy H. Perlis and Edward B. Holson and Stephen J. Haggarty and Georges El Fakhri and Ravi G. Kurumbail and Neil Vasdev},
  title = {{Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET Neuroimaging}},
  booktitle = {Angewandte},
  year = {2016},
  doi = {10.1002/anie.201603797},
}

Loading related content...

Figure